Back to Search

A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, Formerly PT2977) Monotherapy in Participants With Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Advanced Solid Tumors With HIF-2α Related Genetic Alterations

  • Protocol Number: 202108004
  • Principal Investigator: Trikalinos, Nikolaos
  • Cancer Types: Gastrointestinal

For more information on this trial, contact us here:

[email protected]

Brief Summary

Protocol Interventions